Graeme J. Moyle
Corporate Officer/Principal bij Chelsea & Westminster Hospital
Profiel
Graeme J.
Moyle is currently the Director-HIV Research Strategy at Chelsea & Westminster Hospital since 1994.
He previously worked as an Independent Director at Tobira Therapeutics, Inc. Dr. Moyle holds a doctorate degree from the University of Adelaide.
Actieve functies van Graeme J. Moyle
Bedrijven | Functie | Begin |
---|---|---|
Chelsea & Westminster Hospital | Corporate Officer/Principal | 01-01-1994 |
Eerdere bekende functies van Graeme J. Moyle
Bedrijven | Functie | Einde |
---|---|---|
Tobira Therapeutics, Inc. /Old/
Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on developing and commercializing of therapies to treat liver disease, HIV, fibrosis and inflammation. Its lead product candidate, cenicriviroc or CVC, is a proprietary immunomodulator that may be used to treat a number of diseases, including NASH, kidney fibrosis, HIV-1 and others. The company was founded by Eckard Weber in September 2006 and is headquartered in South San Francisco, CA. | Director/Board Member | - |
Opleiding van Graeme J. Moyle
University of Adelaide | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Tobira Therapeutics, Inc. /Old/
Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on developing and commercializing of therapies to treat liver disease, HIV, fibrosis and inflammation. Its lead product candidate, cenicriviroc or CVC, is a proprietary immunomodulator that may be used to treat a number of diseases, including NASH, kidney fibrosis, HIV-1 and others. The company was founded by Eckard Weber in September 2006 and is headquartered in South San Francisco, CA. | Health Technology |
Chelsea & Westminster Hospital |